C. Guillemot

Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myélome (IFM

O. Decaux, P. Moreau, H. Avet-Loiseau, 2021, Blood.

New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.

J. Devoisselle, F. Quignard, P. Legrand, 2012, International journal of pharmaceutics.